Donepezil, Residual Excessive Daytime Sleepiness, Obstructive Sleep Apnea

Summary

It is a randomized, double-blind, single-center, 30-day study. Patients aged 35-60 years, with apnea and hypopnea index and respiratory disturbance index normalized with CPAP, and Epworth Sleepiness Scale\> 11. Patients undergo baseline and CPAP titration polysomnography, liquor and blood collection, Multiple Sleep Latency Test, anxiety and depression and cognitive assessments.

Timeline

Start

2018-07-06

Primary completion

2018-11-04

Completion

2019-03-02

Drugs

Indications